Resumen acción THEMISMED
Themis Medicare Limited, junto con sus filiales, fabrica y vende productos farmacéuticos en la India y a escala internacional.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 5/6 |
| Dividends | 1/6 |
Recompensas
Análisis de riesgos
No se han detectado riesgos en THEMISMED a partir de nuestros controles de riesgos.
Competidores de Themis Medicare Limited
Historial de precios y rendimiento
| Historical stock prices | |
|---|---|
| Current Share Price | ₹215.60 |
| 52 Week High | ₹263.85 |
| 52 Week Low | ₹131.61 |
| Beta | 0.61 |
| 1 Month Change | 1.58% |
| 3 Month Change | -0.16% |
| 1 Year Change | 61.70% |
| 3 Year Change | 601.82% |
| 5 Year Change | 629.36% |
| Change since IPO | 1,580.44% |
Noticias y actualizaciones recientes
What Themis Medicare Limited's (NSE:THEMISMED) 42% Share Price Gain Is Not Telling You
Dec 27
Themis Medicare (NSE:THEMISMED) Takes On Some Risk With Its Use Of Debt
Dec 01Recent updates
What Themis Medicare Limited's (NSE:THEMISMED) 42% Share Price Gain Is Not Telling You
Dec 27Themis Medicare (NSE:THEMISMED) Takes On Some Risk With Its Use Of Debt
Dec 01Themis Medicare (NSE:THEMISMED) Has Affirmed Its Dividend Of ₹5.00
Aug 18Themis Medicare's (NSE:THEMISMED) Dividend Will Be ₹5.00
Aug 04Themis Medicare's (NSE:THEMISMED) Dividend Will Be ₹5.00
Jul 18We Think Themis Medicare (NSE:THEMISMED) Is Taking Some Risk With Its Debt
Jul 08Themis Medicare (NSE:THEMISMED) Is Due To Pay A Dividend Of ₹5.00
May 18Themis Medicare (NSE:THEMISMED) Seems To Use Debt Quite Sensibly
Dec 21Themis Medicare (NSE:THEMISMED) Has Announced That It Will Be Increasing Its Dividend To ₹5.00
Aug 28Themis Medicare (NSE:THEMISMED) Is Increasing Its Dividend To ₹5.00
Aug 08Themis Medicare's (NSE:THEMISMED) Upcoming Dividend Will Be Larger Than Last Year's
Jul 21Themis Medicare's (NSE:THEMISMED) Upcoming Dividend Will Be Larger Than Last Year's
May 27Is Now The Time To Put Themis Medicare (NSE:THEMISMED) On Your Watchlist?
May 12Calculating The Fair Value Of Themis Medicare Limited (NSE:THEMISMED)
Nov 09Is Now The Time To Put Themis Medicare (NSE:THEMISMED) On Your Watchlist?
Oct 26Increases to Themis Medicare Limited's (NSE:THEMISMED) CEO Compensation Might Cool off for now
Sep 11Themis Medicare (NSE:THEMISMED) Is Increasing Its Dividend To ₹4.30
Aug 16Do Themis Medicare's (NSE:THEMISMED) Earnings Warrant Your Attention?
Jul 09Estimating The Intrinsic Value Of Themis Medicare Limited (NSE:THEMISMED)
May 14If You Like EPS Growth Then Check Out Themis Medicare (NSE:THEMISMED) Before It's Too Late
Mar 23These 4 Measures Indicate That Themis Medicare (NSE:THEMISMED) Is Using Debt Reasonably Well
Mar 02Why Themis Medicare Limited (NSE:THEMISMED) Is A Top Dividend Stock
Feb 08Themis Medicare Limited's (NSE:THEMISMED) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?
Jan 11
Here's What We Think About Themis Medicare's (NSE:THEMISMED) CEO Pay
Dec 14Does Themis Medicare (NSE:THEMISMED) Have A Healthy Balance Sheet?
Nov 16Are You An Income Investor? Don't Miss Out On Themis Medicare Limited (NSE:THEMISMED)
Oct 21Themis Medicare Limited (NSE:THEMISMED) Looks Interesting, And It's About To Pay A Dividend
Sep 13Rentabilidad de los accionistas
| THEMISMED | IN Pharmaceuticals | Mercado IN | |
|---|---|---|---|
| 7D | -6.6% | -2.1% | -0.03% |
| 1Y | 61.7% | 57.5% | 46.9% |
Rentabilidad frente al sector: THEMISMED superó al sector Indian Pharmaceuticals , que obtuvo un rendimiento del 59.6% el año pasado.
Rentabilidad vs. Mercado: THEMISMED superó al mercado Indian, que obtuvo un rendimiento del 19.4% el año pasado.
Volatilidad de los precios
| THEMISMED volatility | |
|---|---|
| THEMISMED Average Weekly Movement | 7.0% |
| Pharmaceuticals Industry Average Movement | 5.9% |
| Market Average Movement | 6.8% |
| 10% most volatile stocks in IN Market | 10.1% |
| 10% least volatile stocks in IN Market | 4.2% |
Precio estable de las acciones: THEMISMED no ha tenido una volatilidad de precios significativa en los últimos 3 meses.
Volatilidad a lo largo del tiempo: La volatilidad semanal de THEMISMED (7%) se ha mantenido estable durante el año pasado.
Acerca de la empresa
| Fundada | Empleados | CEO | Página web |
|---|---|---|---|
| 1952 | 996 | Sachin Patel | www.themismedicare.com |
Themis Medicare Limited, junto con sus filiales, fabrica y vende productos farmacéuticos en India y a escala internacional. Ofrece principios activos farmacéuticos (API) y formulaciones para su uso en diversas áreas terapéuticas, como antituberculosis, antimaláricos, cardiología, tratamiento del dolor, antiinfecciosos, hematológicos, salud y nutrición, anestesia, ginecología y ortopedia, así como antiinflamatorios no esteroideos. La empresa era conocida anteriormente como Themis Chemicals y cambió su nombre por el de Themis Medicare Limited en 2001.
Resumen de fundamentos de Themis Medicare Limited
| Estadísticas fundamentales de THEMISMED | |
|---|---|
| Capitalización bursátil | ₹19.86b |
| Beneficios(TTM) | ₹452.86m |
| Ingresos (TTM) | ₹3.64b |
43.8x
Ratio precio-beneficio (PE)5.5x
Ratio precio-ventas (PS)¿Está THEMISMED sobrevalorada?
Ver valor justo y análisis de valoraciónBeneficios e Ingresos
| Cuenta de resultados (TTM) de THEMISMED | |
|---|---|
| Ingresos | ₹3.64b |
| Coste de los ingresos | ₹1.28b |
| Beneficio bruto | ₹2.36b |
| Otros gastos | ₹1.91b |
| Beneficios | ₹452.86m |
Últimos beneficios comunicados
Dec 31, 2023
Próxima fecha de beneficios
May 30, 2024
| Beneficios por acción (BPA) | 4.92 |
| Margen bruto | 64.89% |
| Margen de beneficio neto | 12.44% |
| Ratio deuda/patrimonio | 26.0% |
¿Cómo se ha desempeñado THEMISMED a largo plazo?
Ver rendimiento histórico y comparativa